As previously disclosed, Chembio Diagnostics, Inc. (“Chembio” or the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated as of January 31, 2023, with Biosynex SA, a ...
HAUPPAUGE, N.Y., May 04, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has attained ...
Medford-based Chembio Diagnostics and the Foundation for Innovative New Diagnostics are developing a rapid diagnostic test for hepatitis C virus. The foundation is working with three companies on HCV ...
MEDFORD, N.Y., Nov. 04, 2019 (GLOBE NEWSWIRE) -- November 4, 2019 - Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today ...
Chembio Diagnostics has begun selling its Sure Check HIV ½ rapid HIV test in the United States under its own brand name and is lowering prices for all its HIV testing products in this country. The ...
As previously communicated, Chembio Diagnostics, Inc. (“Chembio” or the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated as of January 31, 2023, with Biosynex SA ...
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Shares of Chembio Diagnostics Inc slumped more than 60% on Wednesday after the U.S. Food and Drug Administration (FDA) ...
MEDFORD, N.Y., March 03, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, is providing an update on the ...
HAUPPAUGE, N.Y., March 31, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the U.S. launch ...
A manufacturer of rapid diagnostic tests in Hauppauge has paid $500,000 to end an investigation by the U.S. Securities and Exchange Commission, according to a securities filing. Chembio Diagnostics ...
Chembio Diagnostics Inc. reported a smaller loss for the April-June period compared with a year earlier on increased sales of its rapid tests for HIV, syphilis and tropical diseases. The Medford-based ...
(Reuters) - A U.S. judge has dismissed claims that Chembio Diagnostics Inc defrauded investors by overstating the accuracy of its COVID-19 antibody test in the early months of the pandemic, but will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results